Introduction
Atrial fibrillation (AF) is the most common arrhythmia of the heart, and it is associated with an increased risk of ischaemic strokes, [1] [2] [3] heart failure, 4 and premature death 5 among others. The incidence of AF is shown to be positively correlated with the age, male sex, diabetes, hypertension, congestive heart failure, valve disease, and myocardial infarctions. [6] [7] [8] In addition, AF is associated with a 1.5-to 1.9- fold mortality risk even after adjusting for related pre-existing cardiovascular conditions. 5 Prehypertension and an impaired fasting glucose (IFG) are the prior stages to the two well-known AF risk factorshypertension and diabetes, respectively, and because prehypertension and IFG are common worldwide and are considered clinically normal, 9 antihypertensive treatments of these conditions are rare.
Only in the last few decades were prehypertension and IFG brought to attention for their direct association with cardiovascular diseases. 10 Therefore, in regards to public health, it is critical to address the possible association of prehypertension and pre-diabetes with new onset AF. Although some studies have looked into prehypertension 11, 12 and IFG 13 in the context of AF, the answers to some of the more detailed and important questions, for example, whether prehypertensive systolic or the diastolic pressure differentially contributes to the AF risk or whether some other confounding factors are involved, are contested. Because AF is associated with multiple lifethreatening conditions such as ischaemic strokes, and also has numerous risk factors of its own, accurately identifying the risk factors and allocating the right amount of attention and resources to the underlying conditions are crucial for successful patient care and prophylaxis. Therefore, we conducted a large, comprehensive cohort study on a healthy Korean adult population without the traditional risk factors and co-morbidities in an attempt to identify the direct association of prehypertension and IFG with new onset AF. Furthermore, because the risks imposed by baseline characteristics can depend on regional and ethnic differences, 14, 15 we also focused on the endemic (the Asian cohort) relevance of pre-ypertension, an IFG, and the body mass index (BMI) related to new onset AF.
Methods

Data source
This study was based on the Korean National Health Insurance Service (NHIS) Sample Cohort database from 2002 to 2013. 16 This cohort was not a randomized sampled method, and a sample cohort was extracted by probability sampling from all beneficiaries of the National Health insurance and National Medical Aid in 2002 depending on the entire national cohort information. Systematic sampling was acquired from each 1476 Figure 1 Study cohort. § Subgroup: life style questionnaires (smoking, alcohol), body mass index, blood pressure, previous myocardial infarctions, heart failure, hypertension, diabetes mellitus, and strokes. † NHIS-NSC denotes National Health Insurance Service-National Sample Cohort.
strata based on the age, gender, eligibility status, and income level with the sample size proportionate to the cohort size of the strata. The Sample Cohort database consisted of the dataset of the sociodemographic information of the beneficiaries, medical claims dataset including information on the diagnosis based on the 10th revision of the International Classification of Disease (ICD-10) codes, admission, and treatment, and the National Health Screening dataset of the cohort members. The National Health Screening data were composed of a health check-up database conducted for the entire Korean population from 2002 to 2013 by the National Health Insurance Corporation. The National Health check was conducted biennially, and included regular blood tests, chest X-ray examinations, physical examinations of the patients, and questionnaires on their medical history. It was known that about 70% of the entire cohort underwent a national health check. The death registration database of the Korea National Statistical office (KNSO), including the date of the death and cause of the death were linked with the NHIS cohort database. Every population in the sample cohort was linked by the Korean social security numbers, and all social security numbers were deleted after constructing the cohort by giving serial numbers to prevent leakage of personal information.
Study cohort
This study was designed for adults (n = 410 626) over 20 years of age receiving National Health check-ups at least once between 2003 to 2008 among the total population (n = 1 025 340) included in the Sample Cohort (NHIS-2016-2-189). 16 Further, the subjects who were matched with the exclusion criteria as follows were excluded ( Figure 1) . (i) Those under an age of 20, (ii) those diagnosed with AF (ICD-I48) before conducting the health check-ups, (iii) those with valvular AF such as mitral valve stenosis and prosthetic valve disease (ICD-I050, I052, I342), and (iv) those missing data in the questionnaire for smoking and alcohol at the health check-ups. Among them (366 507 population), the populations with heart failure, hypertension, diabetes mellitus, strokes, vascular disease, and other diseases were additionally excluded (139 306 population). So finally, a population of 227 102 patients was included for the analysis (Figure 1) . In addition, we excluded the population with malignancy (C00-96; n = 12 023), pulmonary disease (COPD; J41-44; n = 20 266/asthma; J45-46; n = 31 346), and autoimmune disease (n = 10 915) (rheumatoid arthritis; M05-06, systemic connective disorders; M30-36, systemic lupus erythematosus; M32, ankylosing spondylitis; M45, juvenile arthritis; M08) to define a healthy population with a more strict criteria (see Supplementary material online, Table S2 ). Each diagnosis was defined as the first occurrence during at least two different days of hospital visits (outpatient) or on the first admission, as likely a diagnosis of AF.
Life style and other variables
The age was graded every 5 years from 20 years old. A past history including congestive heart failure, hypertension, diabetes, strokes, and vascular disease were analysed by the existence of medical claim data with an ICD code (I50, I10-I15, E10-E14, I60-I69, I20-I25, and I71, I72, respectively) and questionnaires on the disease history and measurement of the blood pressure (BP) and fasting glucose level in health check-ups. Prehypertension was defined as a BP between 120-139 or 80-89 mm Hg. 12, 17 Further, an IFG was defined as a fasting plasma glucose level 18, 19 Smoking and alcohol were classified by questionnaires from the health check-ups. Smoking was divided as exor current smokers, and non-smokers and the frequency of the alcohol intake was classified as non-, 1-3 times/month, 1-2 times/week, and > _3 times/week. The outcome was the incidence of AF, and an AF incidence was defined as the first occurrence during at least two different days of hospital visits (outpatient) or the first admission, or death with a diagnosis of AF as the ICD-10 code (I48). 20, 21 To evaluate the accuracy of our definition of AF, we conducted a validation study in two hospitals with 628 randomly chosen patients with the ICD-10 code I48. Their electrocardiograms (ECGs) were reviewed by two physicians (DHK and JBP). The patients were ascertained to have AF if it was documented by ECG examinations. The positive predictive value was 94.1%. The primary outcome was an acute ischaemic stroke (ICD-10 code I63), when excluding transient ischaemic attacks (TIAs) or other kinds of thromboembolisms.
To avoid an overestimation of the stroke risk associated with AF, we used a blanking period of 4 weeks after the index date, and excluded events that occurred immediately following the initial diagnosis of AF. 22 The cohort was followed up at the time of an AF incidence, disqualification of the National Health Insurance Service (death or immigration), or the end of the study (31 December 2013). The mean follow-up duration was 7.7 ± 2.1 years. The accuracy of the diagnosis of an ischaemic stroke in the NHIS claim data was previously validated. 16 
Statistical analysis
The frequency (and proportion) of AF was described depending on the age (15-year interval age group), gender, and comorbidities. Further, Cox regression analyses were used to analyse the association between the life styles (smoking and alcohol intake) and AF incidence. Models for adjusting for the clinical variables were used to assess the association. The multivariable model included the age (5 year), gender, BMI, BP, and life styles (smoking or alcohol). 23 A P-value <0.05 was considered statistically significant. The proportionality of the hazards assumption was checked with a log minus log graph and a test on the Schoenfeld residuals, and as a consequence, the test results were valid for each life style. The AF incidence of Figure 2 was represented as 'per person-year' to provide more accurate comparisons among groups because follow-up time was not the same in all groups. We expressed a rate of events per 100 000 patient-years. All statistical analyses were performed with SAS software (version 9.2, SAS Institute, Cary, NC, USA).
Results
Baseline characteristics
In all, 0.7% of the population developed new onset AF during a mean follow-up of 7.7 ± 2.1 years in the healthy population. The risk of an AF incidence was higher in males than females and increased with an advancing age ( ) and the population with a frequent alcohol intake (frequency > _3 times a week, HR = 1.27) had an increased risk of new onset AF ( Table 1) . Supplementary material online, Table S2 represents the baseline characteristics of a healthy population with a more strict criteria and shows a similar tendency as compared with that of the healthy population by the initial inclusion criteria.
Subjects with diastolic prehypertension were at increased risk of new onset atrial fibrillation
Subjects with a high diastolic BP had a higher risk of new onset AF compared with those with a high systolic BP even after adjusting for the clinical variables (HR = 1.11, P = 0.045). Further, subjects who had both high diastolic and systolic BPs were at a higher risk of new onset AF than those subjects with neither condition (HR = 1.13, P = 0.039), the risk also showed a similar tendency (HR = 1.12, P = 0.056) even when adjusted for the clinical variables ( Table 2) . However, subjects with prehypertension, by definition, did not have a significant association with new onset AF compared with those without the condition (HR = 1.09, P = 0.98).
Impaired fasting glucose was associated with a higher risk of new onset atrial fibrillation
Based on two mainstream guidelines of determining an IFG, one provided by the ADA guideline and another from the WHO, we found that an IFG was associated with a higher risk of new onset (Table 3) . Using the ADA guidelines, having a fasting blood glucose level of 100-125 mg/dL was associated with a higher AF risk (HR = 1.16, P = 0.017), and according to the WHO guidelines, having an elevated fasting blood glucose level of 110-125 mg/dL was also associated with a higher risk of new onset AF (HR = 1.21 P = 0.040).
The incidence of new onset atrial fibrillation depending on body mass index grouping
After dividing the subjects into two mutually exclusive groups, the Figure 2A (left) showed that AF incidence was increased dramatically by the combination effect of both prehypertension and an IFG in BMI <25 kg/m 2 group, but, in BMI м25 kg/m 2 group, did not show this tendency. Figure 3 presented AF incidence and risk based on the combination of risk factors. Even for a healthy population without comorbidities, the combination of both prehypertension and an IFG increased the risk of AF significantly [HR 1.27 Figure 2B-D) . Figure 2B -D shows the incidence of strokes, HF, and mortality in a healthy population group with the same inclusion criteria. In the analysis of strokes and HF, the population with both pre-HTN and IFG had a higher incidence than that in the other groups, and the BMI м25 kg/m 2 groups had a higher incidence than the BMI <25 kg/m 2 group.
Relative risk of an impaired fasting glucose for new onset atrial fibrillation was more prominent in the body mass index <25 kg/m 2 group Table 4) . The group analysis in the population with a BMI <20 kg/m 2 had a similar tendency as the normal BMI group. In the BMI <20 kg/m 2 group, the combination of pre-HTN and a IFG were likely to increase (HR: from 1.09 to 1.47 ) the risk of new onset AF as in those in the normal BMI group (HR: from 1.13 to 1.26) ( Table 4) . Supplementary material online, Table S3 represents the BMI dependent prehypertension and IFG risk on the incidence of AF in a healthy population with a more strict criteria. Further, the results show a more significant tendency in all groups including the low BMI group as compared with that of Table 4 .
Discussion
Even for a healthy population without comorbidities, each occurrence of an IFG and prehypertension was associated with the incidence of AF, and the combination of an IFG and prehypertension also exhibited additive effects; furthermore, the relationship between an AF incidence and the two risk factors was more prominent in the BMI <25 kg/m 2 group than in the BMI м25 kg/m 2 group in the healthy Asian population.
Clinical importance of an impaired fasting glucose and prehypertension on the atrial fibrillation risk
Atrial fibrillation is a risk factor of fatal cardiovascular diseases including strokes [1] [2] [3] and heart failure 4 ; moreover, the AF incidence itself is associated with risk factors including hypertension and diabetes. 6, 7 While diseases such as hypertension and diabetes are treated under a typical health care system, the stages prior to these conditions, prehypertension and IFG, are normally left untreated. If prehypertension and IFG are in fact important risk factors of new onset AF, the neglect of patients with these underlying conditions may be critical to the public health. To observe the role of prehypertension and IFG as potential independent risk factors of AF, we conducted a cohort 
Unique characteristics of an Asian population regarding the atrial fibrillation risk
In our study, an IFG and diastolic prehypertension were associated with a higher risk of new onset AF in a healthy population. Our findings that prehypertension and IFG were associated with new onset AF confirmed the results of other previous studies. [11] [12] [13] However, in partial contrast to the results of those studies, 11, 12 our data suggested that the diastolic, not the systolic BP in the pre-hypertensive range was indicative of new onset AF. The contrast likely is derived from the regional endemic differences in the population as the systolic BP is correlated with the AF incidence in American women 11 and men, 12 while our findings were derived from a large cohort of an Asian population, and the mechanisms through which these differences arose should be further studied. There has been conflicting evidence related to the possible risk related to cardiovascular disease in the diastolic BP. Many trials revealed a J-shaped curve in which the risk of cardiac events declines as the diastolic pressure falls from above 100 mmHg to 80 mmHg, but then rises back up at pressures below 75 to 80 mmHg, rather than demonstrating a progressive benefit at lower pressures. [24] [25] [26] In addition, the relative risk of an IFG with new onset AF was significant only in subjects with a BMI <25 kg/m 2 , while prehypertension remained less significant. In general, the Asian population has a low BMI and less obese demographic characteristics compared with the Western population. Further, it is known that Asian populations have a higher risk of developing cardiovascular diseases than Caucasians with an equivalent BMI, 15 and thus there is an ongoing debate whether there should be separate BMI indices for Asian populations. 14 In the Asian population, a high BMI may be a much stronger risk factor of new onset AF compared with Caucasians. In that case, the statistical significance of an IFG on the AF incidence is shadowed by the relatively large significance of a high BMI when the two conditions are presented together. Thus, there are important clinical implications for searching for other risk factors in an Asian population with a low or normal BMI. Therefore, we additionally analysed the low or normal BMI group in detail. However, unlike the previous study, a low BMI (BMI <20 kg/m 2 ) did not exhibit any additional risk of AF (Table 1) . Further, a segmented linear regression of the BMI (see Supplementary material online, Table S1 ) also showed the same results in the high BMI groups compared with the previous Asian study, 27 but did not show any significant association in the low BMI group. In that previous Asian study, 27 the low BMI group may have included a larger population with comorbidities (hypertension, diabetes, cardiovascular disease, heart failure, and strokes) or a poor general condition. Therefore, our study design excluded the population with comorbidities related to AF to control for any complex interactions from the beginning. So, we included just a high BMI as the risk factor for AF. Though the directions of causality and underlying 
Study strengths compared with previous reports
There are multiple studies on the AF incidence and clinical outcome depending on hypertension and type 2 diabetes; 8,17,28 however, there are limited studies on the effect of prehypertension and an IFG on new onset AF. Even the few studies on prehypertension and an IFG tended to be smaller scaled with a few thousand subjects, 12,13,29 of which a very small proportion develop AF, or were limited to a narrow age group of a particular sex. 11, 29 In contrast, our study had the following advantages: It included (i) a large scaled adult cohort (ages >19) of over 200 000 subjects that underwent national health checkups that were enrolled in the Korean NHID cohort, (ii) a long-term follow-up duration of more than a mean of 7 years, and (iii) excluded the population with comorbidities to analyse the direct effect of prehypertension and an IFG on new onset AF in a healthy population.
With a large sample sized cohort, we eliminated much of the large statistical error in our sample mean and proportions. In addition, sampling diverse age groups and both sexes endowed us a tool to adjust for our own baseline characteristics. Finally, sampling a healthy population without comorbidities was the key to solely focus on the direct effect of prehypertension and an IFG by controlling for other associated variables of new onset AF.
Clinical implications
Our study supported that prehypertension and an IFG have a significant association with new onset AF in a healthy population without comorbidities. However, perhaps the most clinically significant finding is that the effect of prehypertension and an IFG was statistically irrelevant for subjects with a BMI > _25 kg/m 2 . Previous studies have shown that the causation indeed does run from a high BMI, which is an indicator of obesity, to a host of metabolic and cardiovascular diseases, including AF and diabetes. 30 Therefore, for those with prehypertension and/or IFG with a high BMI, a tight control of the BMI in a range of <25 kg/m 2 may be the most crucial first step in AF prophylaxis.
Secondarily, controlling the BP and blood glucose in the prehypertensive and pre-diabetic range, respectively, in a healthy population, may be an additional prophylactic measure for preventing new onset AF. Both of these goals may be largely met by improving exercise and nutritional regimens and other life style patterns with the additional option of modern drug therapy.
Limitations
Our study, nonetheless, had its limitations. First, our study involved a homogeneous cohort, and despite the advantage of a high relevance for Korean and Asian populations in general, it also suggested that our findings may not be perfectly applicable to other groups of populations. The reproducibility and applicability should be tested by future studies in other cohorts as well. Further, we were unable to adjust for variables that required costly, extensive diagnostic examinations such as echocardiography. For example, a relevant variable, the left atrial size, is strongly associated with an AF incidence and the effect of the BMI is largely eliminated once the left atrial size is taken into account, and this finding implies that a high BMI and obesity lead to an enlarged left atrium, which then directly elevates the risk of new onset AF. 30 Thus with our current statistical variables, although it may be plausible that lowering the BMI will lead to a reduction in the new onset AF risk, if atrial enlargement is already present in a high BMI subject, such a recommendation may not be too effective. And we could not analyse the biomarkers, inflammatory markers such as the C-reactive protein, atrial natriuretic peptide, and brain natriuretic peptide, and cardiac enzymes. Further, we could not be sure of any asymptomatic or undiagnosed AF in the patients before entering them in the study, because of the characteristics of the epidemiologic cohort data. Finally, high-intense physical activity can influence the incidence of AF, and there may have been a difference in the intense physical activity between the genders. Unfortunately, the health check-up data on exercise did not consist of a standard questionnaire that included the exercise intensity, frequency, or time, and as a consequence, we could not analyse the effect of physical activity.
Conclusion
An IFG and diastolic prehypertension were associated with a higher risk of new onset AF in a healthy population without comorbidities. The relative risk of an IFG on new onset AF was significant in the subjects with a BMI <25 kg/m 2 , and prehypertension had an additive effect when combined with an IFG. Finally, when prehypertension was combined with the IFG, the risk of new onset AF was increased especially in the BMI <25 kg/m 2 group, and a high BMI > _25 kg/m 2 was the most prominent risk factor.
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